Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Profile of lower urinary tract symptoms in the male and their impact on quality of life.

Cambronero J, Arlandis S, Errando C, Mora AM.

Actas Urol Esp. 2013 Jul-Aug;37(7):401-7. doi: 10.1016/j.acuro.2012.11.011. Epub 2013 Feb 12. English, Spanish.

PMID:
23411069
[PubMed - indexed for MEDLINE]
2.

Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study.

Fukuta F, Masumori N, Mori M, Tsukamoto T.

BJU Int. 2012 Oct;110(7):1023-9. doi: 10.1111/j.1464-410X.2011.10866.x. Epub 2012 Jan 11.

PMID:
22233355
[PubMed - indexed for MEDLINE]
3.

Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia.

Fourcade RO, Lacoin F, Rouprêt M, Slama A, Le Fur C, Michel E, Sitbon A, Cotté FE.

World J Urol. 2012 Jun;30(3):419-26. doi: 10.1007/s00345-011-0756-2. Epub 2011 Sep 3.

PMID:
21892656
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.

Fujimura T, Kume H, Nishimatsu H, Sugihara T, Nomiya A, Tsurumaki Y, Miyazaki H, Suzuki M, Fukuhara H, Enomoto Y, Homma Y.

BJU Int. 2012 May;109(10):1512-6. doi: 10.1111/j.1464-410X.2011.10445.x. Epub 2011 Aug 26.

PMID:
21883834
[PubMed - indexed for MEDLINE]
5.

Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.

Kaplan SA, Roehrborn CG, Chancellor M, Carlsson M, Bavendam T, Guan Z.

BJU Int. 2008 Nov;102(9):1133-9. doi: 10.1111/j.1464-410X.2008.07761.x. Epub 2008 May 26.

PMID:
18510659
[PubMed - indexed for MEDLINE]
6.
7.

Association between the self-perception period of lower urinary tract symptoms and the International Prostate Symptom Score.

Shim SR, Kim JH, Kim KH, Yoon SJ, Lee WJ, Kim HJ, Bae JH.

Urol Int. 2012;88(4):431-7. doi: 10.1159/000334913. Epub 2012 Mar 8.

PMID:
22414894
[PubMed - indexed for MEDLINE]
8.

Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.

Kaplan SA, Roehrborn CG, Gong J, Sun F, Guan Z.

BJU Int. 2012 Jun;109(12):1831-40. doi: 10.1111/j.1464-410X.2011.10624.x. Epub 2011 Oct 3.

PMID:
21966995
[PubMed - indexed for MEDLINE]
9.

Prevalence of post-micturition symptoms in association with lower urinary tract symptoms and health-related quality of life in men and women.

Maserejian NN, Kupelian V, McVary KT, Doshi M, Link CL, McKinlay JB.

BJU Int. 2011 Nov;108(9):1452-8. doi: 10.1111/j.1464-410X.2010.10014.x. Epub 2011 Jan 11.

PMID:
21223471
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Content validity of the Benign Prostatic Hyperplasia Impact Index (BII); a measure of how urinary trouble and problems associated with BPH may impact the patient.

Kingery L, Martin ML, Naegeli AN, Khan S, Viktrup L.

Int J Clin Pract. 2012 Sep;66(9):883-90. doi: 10.1111/j.1742-1241.2012.02960.x.

PMID:
22897465
[PubMed - indexed for MEDLINE]
11.

Moving towards a comprehensive assessment of lower urinary tract symptoms (LUTS).

Coyne KS, Barsdorf AI, Thompson C, Ireland A, Milsom I, Chapple C, Kopp ZS, Bavendam T.

Neurourol Urodyn. 2012 Apr;31(4):448-54. doi: 10.1002/nau.21202. Epub 2012 Mar 6.

PMID:
22396308
[PubMed - indexed for MEDLINE]
12.

Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN).

Van Kerrebroeck P, Haab F, Angulo JC, Vik V, Katona F, Garcia-Hernandez A, Klaver M, Traudtner K, Oelke M.

Eur Urol. 2013 Sep;64(3):398-407. doi: 10.1016/j.eururo.2013.03.031. Epub 2013 Mar 19.

PMID:
23537687
[PubMed - indexed for MEDLINE]
13.

Initial combined treatment with anticholinergics and α-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study.

Lee SH, Chung BH, Kim SJ, Kim JH, Kim JC, Lee JY.

Prostate Cancer Prostatic Dis. 2011 Dec;14(4):320-5. doi: 10.1038/pcan.2011.22. Epub 2011 Jul 26.

PMID:
21788967
[PubMed - indexed for MEDLINE]
14.

Debilitating lower urinary tract symptoms in the post-renal transplant population can be predicted pretransplantation.

Dion M, Cristea O, Langford S, Luke PP, Sener A.

Transplantation. 2013 Feb 27;95(4):589-94. doi: 10.1097/TP.0b013e3182782f7e.

PMID:
23263609
[PubMed - indexed for MEDLINE]
15.

International Prostate Symptom Score for assessing lower urinary tract dysfunction in women.

Hsiao SM, Lin HH, Kuo HC.

Int Urogynecol J. 2013 Feb;24(2):263-7. doi: 10.1007/s00192-012-1818-8. Epub 2012 May 16.

PMID:
22588143
[PubMed - indexed for MEDLINE]
16.

Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.

Brock G, Broderick G, Roehrborn CG, Xu L, Wong D, Viktrup L.

BJU Int. 2013 Nov;112(7):990-7. doi: 10.1111/bju.12251. Epub 2013 Aug 13.

PMID:
23937669
[PubMed - indexed for MEDLINE]
17.

Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies.

Angalakuditi M, Seifert RF, Hayes RP, O'Leary MP, Viktrup L.

Health Qual Life Outcomes. 2010 Nov 12;8:131. doi: 10.1186/1477-7525-8-131.

PMID:
21073697
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.

Sacco E, Bientinesi R, Marangi F, Totaro A, D'Addessi A, Racioppi M, Pinto F, Vittori M, Bassi P.

BJU Int. 2012 Dec;110(11 Pt C):E837-44. doi: 10.1111/j.1464-410X.2012.11288.x. Epub 2012 Jun 19.

PMID:
22712582
[PubMed - indexed for MEDLINE]
19.

Sociodemographic and lifestyle factors affecting the self-perception period of lower urinary tract symptoms of international prostate symptom score items.

Kim JH, Shim SR, Lee WJ, Kim HJ, Kwon SS, Bae JH.

Int J Clin Pract. 2012 Dec;66(12):1216-23. doi: 10.1111/j.1742-1241.2012.02988.x.

PMID:
23163502
[PubMed - indexed for MEDLINE]
20.

An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.

Li MK, Garcia L, Patron N, Moh LC, Sundram M, Leungwattanakij S, Pripatnanont C, Cheng C, Chi-Wai M, Loi-Cheong N.

BJU Int. 2008 Jan;101(2):197-202. Epub 2007 Nov 13.

PMID:
18005205
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk